Search
for
Sort by
Research 331–360 of 1000+
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Hair Follicle Reconstruction and Stem Cells
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia universalis. Partial response to tofacitinib
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement